MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
1.61 M |
Market Cap[1] |
$ 37.8 M |
EBITDA (LTM) |
$ -849 K |
P/E (LTM) |
-36.8125 |
P/S (LTM) |
0.609164 |
EPS (LTM) |
-0.64 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
DexCom
DXCM
|
$ 79.92 | -1.42 % | $ 31.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 258.38 | -0.5 % | $ 28.7 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 34.41 | 0.07 % | $ 997 M | Nasdaq Global Market,SPB | USA |
 |
IDEXX Laboratories
IDXX
|
$ 696.77 | -1.4 % | $ 56 B | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 214.84 | -2.69 % | $ 33.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.05 | -3.48 % | $ 99 K | Nasdaq Capital Market | USA |
 |
Biodesix
BDSX
|
$ 10.04 | -2.95 % | $ 75.8 M | Nasdaq Global Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.25 | 7.66 % | $ 6.81 M | Nasdaq Capital Market,SPB | USA |
 |
Bioventus
BVS
|
$ 11.18 | 1.5 % | $ 745 M | Nasdaq Global Select Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 25.83 | -1.22 % | $ 795 M | Nasdaq Global Market | USA |
 |
CareDx, Inc
CDNA
|
$ 80.78 | -4.31 % | $ 4.3 B | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Biomerica
BMRA
|
$ 1.48 | -4.52 % | $ 4.31 M | Nasdaq Capital Market | USA |
 |
Interpace Biosciences
IDXG
|
$ 7.0 | -13.43 % | $ 31 M | Nasdaq Global Select Market | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 204.62 | -1.43 % | $ 16 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Co-Diagnostics
CODX
|
$ 0.29 | -9.5 % | $ 386 K | Nasdaq Capital Market | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 13.19 | 6.46 % | $ 135 M | Nasdaq Global Market |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 2.37 | 15.05 % | $ 9.44 M | Nasdaq Capital Market |  Israel |
 |
Myriad Genetics
MYGN
|
$ 5.66 | -1.39 % | $ 524 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.78 | -1.24 % | $ 3.76 M | Nasdaq Global Select Market | USA |
 |
QIAGEN N.V.
QGEN
|
$ 50.52 | -0.07 % | $ 11 B | NYSE |  Niderland |
 |
NeoGenomics
NEO
|
$ 16.97 | -3.58 % | $ 2.17 B | Nasdaq Global Select Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.71 | 0.58 % | $ 1.28 B | Nasdaq Global Select Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 2.22 | -5.93 % | $ 666 M | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 11.67 | -3.44 % | $ 2.54 B | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 15.9 | -0.31 % | $ 1.42 B | Nasdaq Global Select Market | USA |
 |
Sotera Health Company
SHC
|
$ 16.25 | -1.16 % | $ 4.61 B | Nasdaq Global Select Market | USA |
 |
Quidel Corporation
QDEL
|
$ 11.56 | -4.43 % | $ 487 M | Nasdaq Global Select Market,SPB | USA |
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Trinity Biotech plc
TRIB
|
$ 5.88 | 10.08 % | $ 2.11 B | Nasdaq Global Select Market | Irlanda |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 26.91 | 0.9 % | $ 602 M | Nasdaq Global Select Market | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 132.17 | -2.35 % | $ 7.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Waters Corporation
WAT
|
$ 476.29 | -0.09 % | $ 28.4 B | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 5.26 | -25.92 % | $ 113 M | Nasdaq Global Market | USA |
 |
Celcuity
CELC
|
$ 67.13 | -4.11 % | $ 3.14 B | Nasdaq Global Select Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 370.89 | -0.25 % | $ 30.9 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.